Results 81 to 90 of about 21,287 (236)

LRP5 variants may contribute to ADPKD

open access: yes, 2016
Contains fulltext : 167912.pdf (Publisher’s version ) (Open Access)Mutations in Polycystic Kidney Disease proteins (PKD1 or PKD2) are causative for autosomal dominant polycystic kidney disease (ADPKD).
Hanka Venselaar   +39 more
core   +1 more source

Vascular Endothelial Growth Factor (VEGF) Gene Promoter Polymorphisms and Disease Progression in North Indian Cohort with Autosomal Dominant Polycystic Kidney Disease [PDF]

open access: yesInternational Journal of Molecular and Cellular Medicine, 2017
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by a significant phenotypic variability in progression of the disease. Vascular endothelial growth factor (VEGF) has been reported to play a major role in renal pathophysiology.
Shewata Pandita   +6 more
doaj  

Unilateral autosomal dominant polycystic kidney disease with co-existent renal cell carcinoma: A rare entity

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2018
Bilateral ADPKD is a well-known entity, but there are only a few reports on unilateral ADPKD in adults, most of which had associated contralateral agenesis. Further rare is the development of RCC in unilateral ADPKD.
Anupama Tandon   +4 more
doaj   +1 more source

Tolvaptan in Pediatric Autosomal Dominant Polycystic Kidney Disease: From Here to Where?

open access: yesKidney Diseases, 2021
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder, accounting for approximately 5% of all ESRD cases worldwide.
Fei Liu   +4 more
doaj   +1 more source

Clinical Manifestation, Management and Prognosis of Acute Myocardial Infarction in Autosomal Dominant Polycystic Kidney Disease

open access: yesKidney & Blood Pressure Research, 2018
Background/Aims: Cardiovascular complications are the most common cause of death in individuals with autosomal dominant polycystic kidney disease (ADPKD), yet there is no substantial data concerning the clinical characteristics of acute myocardial ...
Bo Yang, Qi Wang, Rui Wang, Tao Xu
doaj   +1 more source

Overview of ADPKD in Pregnancy

open access: yesKidney International Reports
Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disorder that often affects patients in their third to fifth decades of life and is characterized by kidney cysts, chronic kidney disease (CKD), hypertension, and hepatic cysts. The development of clinical symptoms often coincides with childbearing years. Consequently, there are several
Ruth E. Campbell   +2 more
openaire   +3 more sources

Capillary Endothelia from Two ADPKD Patients are Polyploidy [PDF]

open access: yes, 2016
Bilateral renal cyst formation is the main feature of autosomal dominant polycystic kidney disease (ADPKD). We and other laboratories have previously shown that cystlining epithelia of kidneys from ADPKD patients are characterized by polyploidy.
AbouAlaiwi, Wissam A.   +3 more
core   +1 more source

Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe

open access: yesBMC Nephrology, 2020
Background Autosomal dominant polycystic kidney disease (ADPKD) is considered the most common inherited renal disease. Patient-Reported Outcomes (PROs) and patient experience in ADPKD are difficult to quantify and have not been well studied, particularly
Dominique Joly   +6 more
doaj   +1 more source

Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan.

open access: yesAmerican Journal of Kidney Diseases, 2019
RATIONALE & OBJECTIVE The vasopressin V2 receptor antagonist (V2RA) tolvaptan is the first drug that has been shown to slow the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).
B. Kramers   +4 more
semanticscholar   +1 more source

Cardiovascular Complications in ADPKD

open access: yesKidney International Reports
Autosomal dominant polycystic kidney disease (ADPKD), primarily caused by mutations in the PKD1 or PKD2 gene, is among the most common hereditary kidney diseases worldwide and is associated with significant extrarenal manifestations, including cardiovascular disease.
Ebrahimi, Niloufar   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy